Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-22-008208

EVP, Research & CSO sold 1,375 shares at $33.94 ($46,668)

  • EVP, Research & CSO acquired 1,375 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Virgin Herbert EVP, Research & CSO 2022-02-08 Option exercise +1,375 $1.53 $2,104 109,075 D
Virgin Herbert EVP, Research & CSO 2022-02-08 Sale −1,375 $33.94 $46,668 107,700 D
Derivatives
Virgin Herbert EVP, Research & CSO 2022-02-08 Option exercise · Stock Option (Right to Buy) −1,375 220,880 D
Open-market sales · 1,375 sh · avg $33.94 · $46,668
Loading xslF345X03/doc4.xml…